Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

PM

Philip Morris International Declares $1.35 Dividend

Philip Morris International Inc. has declared a regular quarterly dividend of $1.35 per common share, payable on April 10, 2025, to shareholders of record as of March 20, 2025. The ex-dividend date is also March 20, 2025.

The company has been actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Philip Morris International has invested over $14 billion since 2008 to develop, scientifically substantiate, and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes.

In 2022, Philip Morris International acquired Swedish Match, a leader in oral nicotine delivery, creating a global smoke-free champion led by the companies’ IQOS and Zyn brands. As of December 31, 2024, the company's smoke-free products were available for sale in 95 markets, and an estimated 38.6 million adults around the world use Philip Morris International's smoke-free products. The smoke-free business accounted for approximately 39% of the company’s total full-year 2024 net revenues.

The press release did not provide specific comparative metrics from the previous period. Following these announcements, the company's shares moved 0.3%, and are now trading at a price of $153.61. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS